Drug survival of conventional systemic and biologic therapies for moderate-to-severe psoriasis in clinical practice in Spain: prospective results from the SAHARA study

Background: A better understanding of determinants for drug survival of antipsoriatic agents may guide dermatologists in the right therapeutic choice. Objectives: To describe 2-year drug survival of conventional and biologic antipsoriatic treatments. Methods: SAHARA was a prospective study in patien...

Full description

Bibliographic Details
Main Authors: Luis Puig, José-Manuel Carrascosa, Esteban Daudén, Sara Sulleiro, Cristina Guisado
Format: Article
Language:English
Published: Taylor & Francis Group 2020-05-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:http://dx.doi.org/10.1080/09546634.2019.1597244